AstraZeneca has unveiled an at-home delivery option for its FluMist nasal spray flu vaccine, allowing parents to vaccinate their children without leaving home. This groundbreaking move aims to boost vaccination rates amid declining flu shot coverage.
AstraZeneca's FluMist Home, a nasal flu vaccine available for at-home use, aims to improve vaccination rates among children, especially those afraid of needles. Experts discuss its effectiveness and accessibility.
The Nimbus variant is causing a stir with familiar COVID-19 symptoms and a surge in painful sore throats. Experts weigh in on its spread and vaccine efficacy. Stay informed and protected!
This Thursday, New York City faces rising flu deaths among children, Mayor Adams battles for funding, and the Knicks deliver another thrilling comeback. Plus, Bruce Springsteen stays loyal to Jersey and Brooklyn Beckham's hot sauce is under review!
This flu season has seen the highest number of pediatric deaths since the swine flu pandemic, with alarming statistics emerging from the CDC. Experts warn of a potential undercount and emphasize the need for increased vaccination rates among children.
An Ohio father's nightmare unfolds as his 4-year-old daughter, Locklynn, falls into a coma due to flu complications. Doctors reveal the devastating impact of the virus on young lives. Learn about the risks and the alarming flu season statistics.
In an unprecedented move, U.S. Senators express deep concerns over the FDA's cancellation of a critical VRBPAC meeting, risking vaccine availability during the worst flu season in 15 years. The senators demand accountability and clarity from nominee Dr. Marty Makary.
The recent cancellation of a key FDA meeting on flu vaccine strains has raised alarms among health experts, who fear it could impact vaccine quality and availability. With flu season approaching, is the U.S. prepared to protect its citizens?
Rondi Bishop recounts the harrowing experience of her son Elliot's hospitalization during a severe flu season, highlighting the importance of vaccination amidst rising pediatric cases and complications.
This year's flu season is one of the worst in decades, and with critical FDA meetings canceled, experts warn of potential vaccine shortages and public health risks. Are we ready for the next pandemic?
